MARLINA - T2DM : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin

This study is currently recruiting participants. (see Contacts and Locations)

Verified February 2015 by Boehringer Ingelheim

Sponsor:

Collaborator:

Eli Lilly and Company

Information provided by (Responsible Party):

Boehringer Ingelheim

ClinicalTrials.gov Identifier:

NCT01792518

First received: February 14, 2013

Last updated: February 4, 2015

Last verified: February 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	November 2015
Estimated Primary Completion Date:	October 2015 (Final data collection date for primary outcome measure)